Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 4Gastrointestinal 2Thoracic 1Sarcoma 1Lymphoid 1Gynecologic 1Genitourinary 1

Conditions

Urinary Bladder Neoplasms 6Carcinoma, Transitional Cell 6Carcinoma, Renal Cell 5Melanoma 4Non-Muscle Invasive Bladder Neoplasms 3Uterine Cervical Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Prostatic Neoplasms 2Neoplasm Metastasis 2Muscle Invasive Bladder Cancer 2Mesothelioma 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uveal Melanoma 1Urothelial Carcinoma Bladder 1Urologic Neoplasms 1Urogenital Neoplasms 1Urinary Bladder Diseases 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Testicular Germ Cell Tumor 1Small Cell Lung Carcinoma 1Renal Pelvic Carcinoma 1Pancreatic Neoplasms 1Neoplasms, Unknown Primary 1Neoplasms 1Neoplasm Recurrence, Local 1Muscle Invasive Bladder Cancer (MIBC) 1

Interventions

pembrolizumab 28Docetaxel 21Gemcitabine 19Nivolumab 15Paclitaxel 13Prednisone 12Leuprolide 11pazopanib 10Radiotherapy 10Cisplatin 10Sunitinib 9Sorafenib 9Ipilimumab 8Blood Specimen Collection 8Bevacizumab 8avelumab 7atezolizumab 7Therapeutics 7Thalidomide 7Cyclophosphamide 7Carboplatin 7Standard of Care 6Radiation 6Mitomycin 6Interleukin-2 6Cetuximab 6Axitinib 6padeliporfin 5enzalutamide 5cemiplimab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × tislelizumab × Genitourinary × Clear all
NCT07119996 2025-08-13

Clinical Trial on the Protective Role of Vitamin B3 in Enhancing Immunotherapy for Bladder Cancer Patients

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 1 Not yet recruiting
12 enrolled
Genitourinary

Urinary Bladder Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡